PLOS ONE | April 22, 2010
Read the PublicationShort cycle treatment interruption could reduce toxicity and drug costs and contribute to further expansion of antiretroviral therapy (ART) programs.
Latest publications See All
Report
October 11, 2024
Briefing
September 20, 2024
Op-Ed
September 19, 2024